Quality of Life with Well-Differentiated Thyroid Cancer: Treatment Toxicities and Their Reduction

Abstract

Review of treatment-related symptoms prompted policies to reduce toxicity including amifostine pretreatment for 131I therapy and thyrotropin (synthetic TSH) use in place of iatrogenic hypothyroidism for thyroglobulin testing and scanning.